Immunovia AB (publ) (STO:IMMNOV)
0.1624
-0.0046 (-2.75%)
At close: Mar 27, 2026
Immunovia AB Employees
Immunovia AB had 13 employees as of December 31, 2025. The number of employees increased by 4 or 44.44% compared to the previous year.
Employees
13
Change (1Y)
4
Growth (1Y)
44.44%
Revenue / Employee
52.69K SEK
Profits / Employee
-11.22M SEK
Market Cap
109.24M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 13 | 4 | 44.44% |
| Dec 31, 2024 | 9 | -2 | -18.18% |
| Dec 31, 2023 | 11 | -53 | -82.81% |
| Dec 31, 2022 | 64 | -1 | -1.54% |
| Dec 31, 2021 | 65 | -2 | -2.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Medicover AB | 49,000 |
| Getinge AB | 11,670 |
| Swedish Orphan Biovitrum AB | 1,888 |
| Sectra AB | 1,323 |
| Arcoma AB | 31 |
| Biovica International AB | 24 |
| Scandinavian Real Heart AB (Publ) | 15 |
| Iconovo AB | 13 |
Immunovia AB News
- 4 weeks ago - Immunovia AB (IMMVF) Q4 2025 Earnings Call Highlights: Navigating Financial Challenges and ... - GuruFocus
- 4 weeks ago - Q4 2025 Immunovia AB (publ) Earnings Call Transcript - GuruFocus
- 4 months ago - Immunovia AB (FRA:1YR) Q3 2025 Earnings Call Highlights: Transition to Commercial Stage with ... - GuruFocus
- 4 months ago - Q3 2025 Immunovia AB (publ) Earnings Call Transcript - GuruFocus
- 5 months ago - Q2 2025 Immunovia AB (publ) Earnings Call Transcript - GuruFocus
- 1 year ago - Immunovia publishes the Annual Report for 2024 - PRNewsWire
- 1 year ago - Immunovia provides further positive data from the VERIFI study of its next-generation pancreatic cancer test - PRNewsWire
- 1 year ago - Immunovia to host a webcast to share more data from the successful VERIFI clinical validation study - PRNewsWire